大葉大學圖書館 |

Practical pharmacology for Alzheimer's disease[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.831
書名/作者:	Practical pharmacology for Alzheimer's disease/ by Takashi Kudo ... [et al.].
其他作者:	Kudo, Takashi.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	viii, 141 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Alzheimer's disease.
標題:	Alzheimer's disease - Chemotherapy.
標題:	Alzheimer's disease - Treatment.
標題:	Drugs - Effectiveness.
標題:	Medicine & Public Health.
標題:	Psychopharmacology.
標題:	Neurology.
標題:	Pharmacotherapy.
ISBN:	9783319262062
ISBN:	9783319262048
內容註:	Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
摘要、提要註:	The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
電子資源:	http://dx.doi.org/10.1007/978-3-319-26206-2

Practical pharmacology for Alzheimer's disease[electronic resource] /
Practical pharmacology for Alzheimer's disease[electronic resource] /by Takashi Kudo ... [et al.]. - Cham :Springer International Publishing :2016. - viii, 141 p. :ill., digital ;24 cm.

Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

ISBN: 9783319262062

Standard No.: 10.1007/978-3-319-26206-2doiSubjects--Topical Terms:

343910
Alzheimer's disease.

LC Class. No.: RC523

Dewey Class. No.: 616.831

Practical pharmacology for Alzheimer's disease[electronic resource] /
LDR:02083nam a2200313 a 4500 001 456825
003 DE-He213
005 20160822115934.0
006 m d
007 cr nn 008maaau
008 161227s2016 gw s 0 eng d
020 $a 9783319262062 $q (electronic bk.)
020 $a 9783319262048 $q (paper)
024 7 $a 10.1007/978-3-319-26206-2 $2 doi
035 $a 978-3-319-26206-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.831 $2 23
090 $a RC523 $b .P895 2016
245 0 0 $a Practical pharmacology for Alzheimer's disease $h [electronic resource] / $c by Takashi Kudo ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a viii, 141 p. : $b ill., digital ; $c 24 cm.
505 0 $a Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
520 $a The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
650 0 $a Alzheimer's disease. $3 343910
650 0 $a Alzheimer's disease $x Chemotherapy. $3 520065
650 0 $a Alzheimer's disease $x Treatment. $3 431000
650 0 $a Drugs $x Effectiveness. $3 609250
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Psychopharmacology. $3 372108
650 2 4 $a Neurology. $3 402687
650 2 4 $a Pharmacotherapy. $3 528865
700 1 $a Kudo, Takashi. $3 656509
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-26206-2
950 $a Medicine (Springer-11650)